Sperimentazione in fase di reclutamento = ; Sperimentazione in corso = ; Sperimentazione conclusa = ; Finanziato da un ente associato a IRDiRC = ; Membro di una ERN =

Sperimentazioni cliniche nazionali

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

CAHtalyst: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Adult Subjects With Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment (Phase 3) - AT

Institution: Information not provided - AT

Ulteriori dettagli

SPAGNA

Madrid
ADDRESS: NOT PROVIDED - ES

CAHtalyst: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Adult Subjects With Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment -ES

Institution: Information not provided - ES

Ulteriori dettagli

SPAGNA

Madrid
ADDRESS: NOT PROVIDED - ES

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPR001 (Tildacerfont) in Adult Subjects with Classic Congenital Adrenal Hyperplasia -ES

Institution: Information not provided - ES

Ulteriori dettagli

SPAGNA

Madrid
ADDRESS: NOT PROVIDED - ES

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SPR001 (Tildacerfont) in Reducing Supraphysiologic Glucocorticoid Use in Adult Subjects with Classic Congenital Adrenal Hyperplasia -ES

Institution: Information not provided - ES

Ulteriori dettagli

SPAGNA

Madrid
ADDRESS: NOT PROVIDED - ES

CAHtalyst Pediatric Study: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Pediatric Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment - ES

Institution: Information not provided - ES

Ulteriori dettagli

STATI UNITI

Texas
DALLAS

A Phase 1 Multi-Center Study to Assess the Efficacy and Safety of Abiraterone Acetate as Adjunctive Therapy in Pre-Pubescent Children With Classic 21-Hydroxylase Deficiency - US

University of Texas Southwestern Medical Center

Ulteriori dettagli

Sperimentazioni cliniche internazionali

REGNO UNITO; GRAN BRETAGNA

Greater London
ADDRESS: NOT PROVIDED - GB

A Phase III study of efficacy, safety and tolerability of Chronocort® compared with standard glucocorticoid replacement therapy in the treatment of congenital adrenal hyperplasia.

Institution: Information not provided - GB

Ulteriori dettagli